Physician profile
Brian K Wade
NPI 1013961879
$8,642.15
in general payments reported to CMS, 2019-2025
43 companies · $1,442 in 2025
The $1,442 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $670 · 2021: $1,049 · 2022: $1,161 · 2023: $1,227 · 2024: $1,341 · 2025: $1,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,010.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,407.72 | 2019-2025 | Botox |
| Sumitomo Pharma America, INC. | $1,212.88 | 2023-2025 | Gemtesa, Orgovyx |
| Allergan, INC. | $897.98 | 2019-2022 | |
| Astellas Pharma US INC | $647.18 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Neotract INC. | $385.71 | 2019-2020 | |
| Urovant Sciences INC | $354.67 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $304.70 | 2019-2025 | Adstiladrin |
| Antares Pharma, INC. | $291.52 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $244.49 | 2019-2025 | Porges Coloplast |
| Dendreon Pharmaceuticals LLC | $224.69 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $224.43 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Endo Pharmaceuticals INC. | $224.01 | 2019-2024 | Xiaflex, Aveed |
| Pfizer INC. | $206.81 | 2019-2024 | |
| Intuitive Surgical, INC. | $162.26 | 2019-2024 | |
| Myovant Sciences INC. | $156.53 | 2021-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $141.01 | 2025 | Xiaflex |
| Olympus America INC. | $127.64 | 2022-2025 | Itind System |
| Procept Biorobotics Corporation | $123.32 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Progenics Pharmaceuticals, INC. | $118.52 | 2023-2025 | Pylarify |
| Urogen Pharma, INC. | $115.55 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $107.97 | 2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $102.05 | 2019-2020 | |
| Blue Earth Diagnostics | $85.28 | 2019-2023 | |
| Calyxo, INC. | $80.87 | 2024 | Cvac Aspiration System |
| Hollister Incorporated | $67.30 | 2021-2022 | |
| Halozyme INC | $66.50 | 2023 | |
| 180 Medical, INC. | $57.91 | 2021 | |
| Boston Scientific Corporation | $55.03 | 2019-2021 | |
| Conmed Corporation | $54.21 | 2019 | |
| Axonics, INC. | $45.55 | 2022-2023 | Axonics |
| Tolmar Pharmaceuticals, INC. | $45.38 | 2022 | |
| Travere Therapeutics, INC. | $39.99 | 2019-2021 | |
| Tolmar, INC. | $35.39 | 2024-2025 | Eligard, Jatenzo |
| Medtronic, INC. | $31.75 | 2021 | |
| Convatec INC. | $31.21 | 2019 | |
| Mission Pharmacal Company | $27.66 | 2019-2021 | |
| Baxter Healthcare | $25.65 | 2020 | |
| Immunitybio, INC. | $25.06 | 2025 | |
| Myriad Genetic Laboratories, INC. | $19.68 | 2022 | |
| Laborie Medical Technologies Corp. | $18.48 | 2025 | |
| Amgen INC. | $18.40 | 2019 | |
| Abbott Laboratories | $17.46 | 2022 | |
| Rgh Enterprises LLC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.